Effect of US Drug Enforcement Administration’s Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing
Open Access
- 1 March 2016
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 176 (3) , 399-402
Abstract
Prescription opioid abuse is a major public health problem in the United States.1 The opioid analgesic hydrocodone bitartrate, traditionally available in combination with nonopioid analgesics, is one of the most commonly abused opioids.2 In 2011, hydrocodone combination analgesic products were involved in almost 100 000 abuse-related emergency department visits in the United States, more than double the number in 2004.3Keywords
This publication has 1 reference indexed in Scilit:
- Prescription opioid abuse among enrollees into methadone maintenance treatmentDrug and Alcohol Dependence, 2007